TRPV6 and central nervous system cancer: In oncology, synthetic peptides derived from venoms have reached the clinical development stage, including the chlorotoxin-derived peptide 131I-TM601 for the treatment of gliomas and the soricidin-derived peptide SOR-C13 for solid tumors overexpressing the TRPV6 ion channel [25,26].